Microbiology
Showing page 75 of 254 pages of list content
-
Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain
This article's authors -
The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
This article's authors -
Comparison of SARS-CoV-2 infections among 3 species of non-human primates
This article's authors -
The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement
This article's authors -
Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2
This article's authors -
Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1
This article's authors -
A virus that has gone viral: Amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding and thus infectivity
This article's authors -
Evaluation of heating and chemical protocols for inactivating SARS-CoV-2
This article's authors -
A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing
This article's authors -
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like sequence
This article's authors